Court Says No to Generic Drug Design Lawsuits
WASHINGTON (AP) - The Supreme Court says generic drug manufacturers can't be sued in state court for a drug's design defects if federal officials approved the brand-name version the generic drug copied.
The justices voted 5-4 to agree with generic manufacturer Mutual Pharmaceutical Co, Inc., which wanted a $21 million judgment against it dismissed.
A New Hampshire jury gave that to Karen L. Bartlett after she took sulindac, the generic form of the drug Clinoril, in 2004. It caused her outer skin layer to deteriorate and burn off, leaving at least 60 percent of her body as an open wound. She is also now legally blind.
The federal appeals courts upheld her verdict, but the justices said federal law pre-empts the New Hampshire law that allowed Bartlett's lawsuit.
- Court Stays Execution to Consider Drug Argument
- Carnival Seeks Dismissal of Triumph Lawsuits
- Judge Tosses 3 NY Lawsuits Against Ex-Elmo Actor
- Race-based Claims Thrown Out in Paula Deen Lawsuit
- High Court Sends Back Texas Race-based Plan
- OJ Returns to Las Vegas Court in Bid for New Trial
- O.J. Simpson Heads to Court
- Boy Accused in Killing of His Sister Due in Court
- Court Hearing on Hold Over Lung Transplant Case
- High Court Voids Key Part of Voting Rights Act